Hansoh Pharmaceutical Group Company Ltd Financials

Market Capitalization HK$103.26 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	21.48
Forward PE	34.12
Price to Sales TTM	HK$8.54
Price to Book MRQ	HK$3.70
Enterprise to Revenue	6.51
Enterprise to EBITDA	17.07

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-06-30
Profit Margin	38.97%
Operating Margin	39.92%
Return on Assets TTM	8.33%
Return on Equity TTM	18.10%

Income Statement

Revenue TTM	HK$12,984,178,290
Revenue per Share TTM	HK$2.04
Quarterly Revenue Growth	44.20%
Gross Profit TTM	HK$11,817,227,324
EBITDA	HK$4,062,916,000
Net Income to Common TTM	HK$5,059,456,074
Diluted EPS TTM	HK$0.81
Quarterly Earnings Growth YoY	111.50%

Balance Sheet

Total Cash MRQ	HK$25,218,662,872
Total Cash per Share MRQ	HK$3.96
Total Debt MRQ	HK$
Total Debt to Equity MRQ	0.43
Current Ratio MRQ	7.98
Book Value per Share MRQ	HK$4.70

Cash Flow

Operating Cash Flow TTM	HK$4,993,455,641
Levered Free Cash Flow TTM	HK$3,657,593,624

3692 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	5,934,329,856
Float Shares	1,111,678,976
Avg 10 Volume	4,087,713
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	81.25%
% Held by Institutions	9.89%

Stock Price Summary

Beta	0.65
Fifty Two Week Low	HK$11.18
Fifty Two Week High	HK$22.80
Fifty Two Week Change	30.77%
Day 50 MA	HK$17.75
Day 200 MA	HK$17.97

Dividends and Splits

Forward Annual Dividend Rate	HK$0.40
Forward Annual Dividend Yield	2.31%
Trailing Annual Dividend Rate	HK$0.34
Trailing Annual Dividend Yield	1.97%
Payout Ratio	26.08%
Dividend Date
Ex Dividend Date	2024-09-20
Last Split Factor
Last Split Date